Linezolid Does Not Increase the Risk of Thrombocytopenia in Patients with Nosocomial Pneumonia: Comparative Analysis of Linezolid and Vancomycin Use

Clinical Infectious Diseases

Volumn 37, Issue 12, 2003, Pages 1609-1616

  Nasraway, Stanley A ^a,i   Shorr, Andrew F ^c   Kuter, David J ^b   O'Grady, Naomi ^d   Le, Vu H ^e,g   Cammarata, Sue K ^f,h  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c WALTER REED ARMY MEDICAL CENTER   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e Clinical Biostatistics   (United States)

^f Pharmacia   (United States)

^g PFIZER INC   (United States)

^h NOVARTIS PHARMA AG   (Switzerland)

ⁱ TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; LINEZOLID; VANCOMYCIN;

AGED; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; EPISTAXIS; FEMALE; HOSPITAL INFECTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SIDE EFFECT; STATISTICAL SIGNIFICANCE; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

ACETAMIDES; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CROSS INFECTION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; OXAZOLIDINONES; PNEUMONIA, BACTERIAL; PROSPECTIVE STUDIES; THROMBOCYTOPENIA; VANCOMYCIN;

EID: 0346848723     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/379327     Document Type: Article

References (23)

1. Riska EB, Bostman O, von Bonsdorff H, et al. Outcome of closed injuries exceeding 20-unit blood transfusion need. Injury 1988; 19: 273-6.
2. Stéphan F, Hollande J, Richard O, Cheffi A, Maier-Redelsperger M, Flahault A. Thrombocytopenia in a surgical ICU. Chest 1999; 115: 1363-70.
3. Baughman RP, Lower EE, Flessa HC, Tollerud DJ. Thrombocytopenia in the intensive care unit. Chest 1993; 104:1243-7.
4. Shalansky SJ, Verma AK, Levine M, Spinelli JJ, Dodek PM. Risk markers for thrombocytopenia in critically ill patients: a prospective analysis. Pharmacotherapy 2002; 22:803-13.
5. Strauss R, Wehler M, Mehler K, Kreutzer D, Koebnick C, Hahn EG. Thrombocytopenia in patients in the medical intensive care unit: bleeding prevalence, transfusion requirements, and outcome. Crit Care Med 2002; 30:1765-71.
6. Vanderschueren S, De Weerdt A, Malbrain M, et al. Thrombocytopenia and prognosis in intensive care. Crit Care Med 2000; 28:1871-6.
7. Cawley MJ, Wittbrodt ET, Boyce EG, Skaar DJ. Potential risk factors associated with thrombocytopenia in a surgical intensive care unit. Pharmacotherapy 1999; 19:108-13.
8. Akca S, Haji-Michael P, de Mendonca A, Suter P, Levi M, Vincent JL. Time course of platelet counts in critically ill patients. Crit Care Med 2002; 30:753-6.
9. Bogdonoff DL, Williams ME, Stone DJ. Thrombocytopenia in the critically ill patient. J Crit Care 1990; 5:186-205.
10. Vincent JL, Yagushi A, Pradier O. Platelet function in sepsis. Crit Care Med 2002; 30:S313-7.
11. Patnode NM, Gandhi PJ. Drug-induced thrombocytopenia in the coronary care unit. J Thromb Thrombolysis 2000; 10:155-67.
12. Gerson SL, Kaplan SL, Bruss JB, et al. Hematologic effects of linezolid: summary of clinical experience. Antimicrob Agents Chemother 2002; 46:2723-6.
13. Kuter DJ, Tillotson GS. Hematologic effects of antimicrobials: focus on the oxazolidinone linezolid. Pharmacotherapy 2001; 21:1010-3.
14. Waldrep TW, Skiest DJ. Linezolid-induced anemia and thrombocytopenia. Pharmacotherapy 2002; 22:109-12.
15. Orrick JJ, Johns T, Janelle J, Ramphal R. Thrombocytopenia secondary to linezolid administration: what is the risk [letter]? Clin Infect Dis 2002; 35:348-9.
16. Attassi K, Hershberger E, Alam R, Zervos MJ. Thrombocytopenia associated with linezolid therapy. Clin Infect Dis 2002; 34:695-8.
17. Green SL, Maddox JC, Huttenbach ED. Linezolid and reversible myelosuppression. JAMA 2001; 285:1291.
18. Halpern M. Linezolid-induced pancytopenia [letter]. Clin Infect Dis 2002; 35:347-8.
19. Babcock HM, Fraser V. Clinical experience with linezolid: a case series of 53 patients. Infect Dis Clin Pract 2002; 11:198-204.
20. Rubinstein E, Cammarata S, Oliphant T, Wunderink R. Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study. Linezolid Nosocomial Pneumonia Study Group. Clin Infect Dis 2001; 32:402-12.
21. Wunderink RG, Cammarata SK, Oliphant TH, Kollef MH. Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia. Clin Ther 2003; 25:980-92.
22. Birmingham MC, Rayner CR, Meagher AK, Flavin SM, Batts DH, Schentag JJ. Linezolid for the treatment of multidrug-resistant, gram-positive infections: experience from a compassionate-use program. Clin Infect Dis 2003; 36:159-68.
23. George JN, Raskob GE, Shah SR, et al. Drug-induced thrombocyto-penia: a systematic review of published case reports. Ann Intern Med 1998; 129:886-90.